We introduced three deadlines for applications per year:

EHDN will award seed funds on a competitive basis amongst the submissions at each deadline. A proposal that has not been accepted for funding cannot be re-submitted within 12 months.

Seed funds are intended to fast track the provision of limited funds to investigators for studies that are necessary in order to apply for larger grants from other organisations, or to estimate the power needed for e.g. clinical trials. Studies funded through this scheme should result in conclusive answers to the hypothesis underlying the study. The maximum sum available is €50.000.
All members can apply for seed funds. However, we especially encourage Working Groups to apply in order to encourage discussions and collaborations as well as to avoid unnecessary overlap between individual projects.

Applicants are requested to submit the following information (submission page):

• Name, address, phone number of the applicant and co-applicants
• Name of the institution of the applicant
• Project title and summary (word limit 250 words)
• a sufficiently detailed description of the project (see document below) including an outline of the statistical evaluation (including a power analysis if appropriate, can be uploaded)
• date of application
• Budget summary including if applicable cost for personnel, consumables, materials and supply costs, animal costs, equipment, and other costs.

Upload the document provided below in your submission form.

detailed-seed-fund-description-2012 

Endorsement

Every application will be reviewed by the Scientific and Bioethics Advisory Committee (SBAC).

The SBAC considers the aims, objectives, scientific and clinical adequacy of the applications, qualifications and capabilities of the investigators, mechanisms for funding, sponsorship for the proposed project and the report of the bioethics advisor and any other factors it deems appropriate.
SBAC’s recommendations will then be available to the EHDN Executive Committee. The final decision regarding endorsement of an application rests with the EHDN executive committee also taking into account EHDN's Scientific Strategic Plan. Applicants will be informed about the progress of their application.
If applications are endorsed access to data and/or biomaterials will be granted provided the applicants agree to/that:

• The Data Disclosure Agreement, Material Transfer Agreement, or Research Agreement
• The data from the EHDN database/biomaterials provided will be used for no other purposes than the ones specified in the proposal
• The publication policy will be followed
• A summary of the project (blurb) is posted on the ‘studies in progress’ area of the EHDN public website. The blurb should be no longer than 100 words and describe in simple words (comprehensible for the lay audience) the aims and methods of the project.

Progress reports

Applicants need to provide a progress report summarising the work that has been accomplished. This should consist of two parts:

1. a summary of work accomplished in the last 6 months
2. work planned for the next 6 months

final report with the results of the study. This should detail the objectives, material and methods, results, discussion and conclusions. If you have already submitted or published an abstract or publication, please upload it as well. Please do NOT use the publication itself as final report.